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AMERICAN DIABETES ASSOCIATION
A
tanygiventime,over2millionpeo-
ple are incarcerated in prisons and
jails in the U.S (1). It is estimated
that nearly 80,000 of these inmates have
diabetes, a prevalence of 4.8% (2). In ad-
dition, many more people pass through
the corrections system in a given year. In
1998 alone, over 11 million people were
released from prison to the community
(1). The current estimated prevalence of
diabetes in correctional institutions is
somewhat lower than the overall U.S.
prevalence of diabetes, perhaps because
the incarcerated population is younger
than the general population. The preva-
lence of diabetes and its related comor-
bidities and complications, however, will
continue to increase in the prison popu-
lation as current sentencing guidelines
continue to increase the number of aging
prisoners and the incidence of diabetes in
young people continues to increase.
People with diabetes in correctional
facilities should receive care that meets
national standards. Correctional institu-
tions have unique circumstances that
needtobeconsideredsothatallstandards
of care may be achieved (3). Correctional
institutions should have written policies
and procedures for the management of
diabetes and for training of medical and
correctional staff in diabetes care prac-
tices. These policies must take into con-
sideration issues such as security needs,
transfer from one facility to another, and
access to medical personnel and equip-
ment, so that all appropriate levels of care
are provided. Ideally, these policies
should encourage or at least allow pa-
tients to self-manage their diabetes. Ulti-
mately, diabetes management is
dependent upon having access to needed
medicalpersonnelandequipment.Ongo-
ing diabetes therapy is important in order
to reduce the risk of later complications,
including cardiovascular events, visual
loss, renal failure, and amputation. Early
identiﬁcation and intervention for people
with diabetes is also likely to reduce
short-term risks for acute complications
requiring transfer out of the facility, thus
improving security.
This document provides a general set
of guidelines for diabetes care in correc-
tional institutions. It is not designed to be
adiabetesmanagementmanual.Morede-
tailed information on the management of
diabetes and related disorders can be
found in the American Diabetes Associa-
tion (ADA) Clinical Practice Recommen-
dations,publishedeachyearinJanuaryas
the ﬁrst supplement to Diabetes Care,a s
well as the “Standards of Medical Care in
Diabetes” (4) contained therein. This dis-
cussion will focus on those areas where
thecareofpeoplewithdiabetesincorrec-
tional facilities may differ, and speciﬁc
recommendations are made at the end of
each section.
INTAKE MEDICAL
ASSESSMENT
Reception screening
Reception screening should emphasize
patient safety. In particular, rapid identi-
ﬁcationofallinsulin-treatedpersonswith
diabetes is essential in order to identify
those at highest risk for hypo- and hyper-
glycemia and diabetic ketoacidosis
(DKA).Allinsulin-treatedpatientsshould
have a capillary blood glucose (CBG) de-
termination within 1–2 h of arrival. Signs
andsymptomsofhypo-orhyperglycemia
canoftenbeconfusedwithintoxicationor
withdrawal from drugs or alcohol. Indi-
vidualswithdiabetesexhibitingsignsand
symptoms consistent with hypoglycemia,
particularly altered mental status, agita-
tion, combativeness, and diaphoresis,
should have ﬁnger-stick blood glucose
levels measured immediately.
Intake screening
Patients with a diagnosis of diabetes
should have a complete medical history
and physical examination by a licensed
health care provider with prescriptive au-
thority in a timely manner. If one is not
available on site, one should be consulted
by those performing reception screening.
The purposes of this history and physical
examination are to determine the type of
diabetes, current therapy, alcohol use,
and behavioral health issues, as well as to
screenforthepresenceofdiabetes-related
complications. The evaluation should re-
view the previous treatment and the past
history of both glycemic control and dia-
betes complications. It is essential that
medicationandmedicalnutritiontherapy
(MNT) be continued without interrup-
tion upon entry into the correctional sys-
tem, as a hiatus in either medication or
appropriate nutrition may lead to either
severe hypo- or hyperglycemia that can
rapidly progress to irreversible complica-
tions, even death.
Intake physical examination and
laboratory
All potential elements of the initial medi-
cal evaluation are included in Table 5 of
the ADA’s “Standards of Medical Care in
Diabetes,” referred to hereafter as the
“Standards of Care” (4). The essential
components of the initial history and
physical examination are detailed in Fig.
1. Referrals should be made immediately
if the patient with diabetes is pregnant.
Recommendations
● Patients with a diagnosis of diabetes
shouldhaveacompletemedicalhistory
and undergo an intake physical exami-
nation by a licensed health professional
in a timely manner. (E)
● Insulin-treated patients should have a
CBG determination within 1–2 h of ar-
rival. (E)
● Medications and MNT should be con-
tinuedwithoutinterruptionuponentry
into the correctional environment. (E)
SCREENING FOR DIABETES—
Consistent with the ADA Standards of
Care, patients should be evaluated for di-
abetes risk factors at the intake physical
andatappropriatetimesthereafter.Those
●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●
Originally approved 1989. Most recent revision, 2008.
Abbreviations: CBG, capillary blood glucose; DKA, diabetic ketoacidosis; GDM, gestational diabetes mel-
litus; MNT, medical nutrition therapy.
DOI: 10.2337/dc10-S075
© 2010 by the American Diabetes Association. Readers may use this article as long as the work is properly
cited, the use is educational and not for proﬁt, and the work is not altered. See http://creativecommons.
org/licenses/by-nc-nd/3.0/ for details.
POSITION STATEMENT
care.diabetesjournals.org DIABETES CARE, VOLUME 33, SUPPLEMENT 1, JANUARY 2010 S75whoareathighriskshouldbeconsidered
forbloodglucosescreening.Ifpregnant,a
risk assessment for gestational diabetes
mellitus (GDM) should be undertaken at
the ﬁrst prenatal visit. Patients with clin-
ical characteristics consistent with a high
risk for GDM should undergo glucose
testing as soon as possible. High-risk
women not found to have GDM at the
initial screening and average-risk women
should be tested between 24 and 28
weeks of gestation. For more detailed in-
formation on screening for both type 2
and gestational diabetes, see the ADA Po-
sitionStatement“ScreeningforType2Di-
abetes” (5) and the Standards of Care (4).
MANAGEMENT PLAN— Glyce-
mic control is fundamental to the man-
agement of diabetes. A management plan
to achieve normal or near-normal glyce-
mia with an A1C goal of 7% should be
developed for diabetes management at
the time of initial medical evaluation.
Goals should be individualized (4), and
less stringent treatment goals may be ap-
propriate for patients with a history of se-
vere hypoglycemia, patients with limited
life expectancies, elderly adults, and indi-
viduals with comorbid conditions (4).
This plan should be documented in the
patient’s record and communicated to all
persons involved in his/her care, includ-
ing security staff. Table 1, taken from the
ADA Standards of Care, provides a sum-
mary of recommendations for setting gly-
cemic control goals for adults with
diabetes.
People with diabetes should ideally
receive medical care from a physician-
coordinated team. Such teams include,
but are not limited to, physicians, nurses,
dietitians, and mental health profession-
als with expertise and a special interest in
diabetes. It is essential in this collabora-
tiveandintegratedteamapproachthatin-
dividuals with diabetes assume as active a
roleintheircareaspossible.Diabetesself-
management education is an integral
component of care. Patient self-
management should be emphasized, and
the plan should encourage the involve-
ment of the patient in problem solving as
much as possible.
It is helpful to house insulin-treated
patients in a common unit, if this is pos-
sible, safe, and consistent with providing
access to other programs at the correc-
tional institution. Common housing not
only can facilitate mealtimes and medica-
tion administration, but also potentially
provides an opportunity for diabetes self-
management education to be reinforced
by fellow patients.
NUTRITION AND FOOD
SERVICES— Nutritioncounselingand
menu planning are an integral part of the
multidisciplinary approach to diabetes
management in correctional facilities. A
combinationofeducation,interdisciplinary
communication, and monitoring food in-
take aids patients in understanding their
medical nutritional needs and can facilitate
diabetes control during and after incarcera-
tion.
Nutrition counseling for patients with
diabetes is considered an essential compo-
nent of diabetes self-management. People
with diabetes should receive individualized
MNT as needed to achieve treatment goals,
preferablyprovidedbyaregistereddietitian
familiar with the components of MNT for
persons with diabetes.
Educating the patient, individually or
in a group setting, about how carbohy-
drates and food choices directly affect di-
Figure 1—Essential components of the initial history and physical examination. Alb/Cr ratio, albumin-to-creatinine ratio; ALT, alanine amino-
transferase; AST, aspartate aminotransferase.
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facilitating self-management. This educa-
tion enables the patient to identify better
foodselectionsfromthoseavailableinthe
dining hall and commissary. Such an ap-
proach is more realistic in a facility where
the patient has the opportunity to make
food choices.
The easiest and most cost-effective
means to facilitate good outcomes in pa-
tients with diabetes is instituting a heart-
healthydietasthemastermenu(6).There
should be consistent carbohydrate con-
tent at each meal, as well as a means to
identify the carbohydrate content of each
food selection. Providing carbohydrate
content of food selections and/or provid-
ing education in assessing carbohydrate
content enables patients to meet the re-
quirements of their individual MNT
goals. Commissaries should also help in
dietary management by offering healthy
choices and listing the carbohydrate con-
tent of foods.
Theuseofinsulinororalmedications
may necessitate snacks in order to avoid
hypoglycemia. These snacks are a part of
such patients’ medical treatment plans
andshouldbeprescribedbymedicalstaff.
Timing of meals and snacks must be
coordinated with medication administra-
tion as needed to minimize the risk of hy-
poglycemia,asdiscussedmorefullyinthe
MEDICATION section of this document. For
furtherinformation,seetheADAPosition
Statement “Nutrition Principles and Rec-
ommendations in Diabetes” (7).
URGENT AND EMERGENCY
ISSUES— Allpatientsmusthaveaccess
toprompttreatmentofhypo-andhypergly-
cemia. Correctional staff should be trained
in the recognition and treatment of hypo-
and hyperglycemia, and appropriate staff
should be trained to administer glucagon.
After such emergency care, patients should
be referred for appropriate medical care to
minimize risk of future decompensation.
Institutions should implement a pol-
icy requiring staff to notify a physician of
all CBG results outside of a speciﬁed
range, as determined by the treating phy-
sician (e.g., 50 or 350 mg/dl).
Hyperglycemia
Severehyperglycemiainapersonwithdi-
abetes may be the result of intercurrent
illness, missed or inadequate medication,
or corticosteroid therapy. Correctional
institutions should have systems in place
to identify and refer to medical staff all
patients with consistently elevated blood
glucose as well as intercurrent illness.
Thestressofillnessinthosewithtype
1 diabetes frequently aggravates glycemic
control and necessitates more frequent
monitoring of blood glucose (e.g., every
4–6 h). Marked hyperglycemia requires
temporary adjustment of the treatment
program and, if accompanied by ketosis,
interaction with the diabetes care team.
Adequate ﬂuid and caloric intake must be
ensured. Nausea or vomiting accompa-
nied with hyperglycemia may indicate
DKA, a life-threatening condition that re-
quires immediate medical care to prevent
complicationsanddeath.Correctionalin-
stitutions should identify patients with
type 1 diabetes who are at risk for DKA,
particularly those with a prior history of
frequent episodes of DKA. For further in-
formation see “Hyperglycemic Crisis in
Diabetes” (8).
Hypoglycemia
Hypoglycemia is deﬁned as a blood glu-
cose level 70 mg/dl. Severe hypoglyce-
mia is a medical emergency deﬁned as
hypoglycemia requiring assistance of a
third party and is often associated with
mental status changes that may include
confusion, incoherence, combativeness,
somnolence, lethargy, seizures, or coma.
Signs and symptoms of severe hypoglyce-
mia can be confused with intoxication or
withdrawal. Individuals with diabetes ex-
hibiting signs and symptoms consistent
with hypoglycemia, particularly altered
mental status, agitation, and diaphoresis,
shouldhavetheirCBGlevelscheckedim-
mediately.
Security staff who supervise patients at
risk for hypoglycemia (i.e., those on insulin
or oral hypoglycemic agents) should be ed-
ucated in the emergency response protocol
forrecognitionandtreatmentofhypoglyce-
mia. Every attempt should be made to doc-
umentCBGbeforetreatment.Patientsmust
have immediate access to glucose tablets or
other glucose-containing foods. Hypogly-
cemiacangenerallybetreatedbythepatient
with oral carbohydrates. If the patient can-
notbereliedontokeephypoglycemiatreat-
ment on his/her person, staff members
should have ready access to glucose tablets
or equivalent. In general, 15–20 g oral glu-
cose will be adequate to treat hypoglycemic
events. CBG and treatment should be re-
peated at 15-min intervals until blood glu-
cose levels return to normal (70 mg/dl).
Staff should have glucagon for intra-
muscular injection or glucose for intrave-
nous infusion available to treat severe
hypoglycemia without requiring transport
of the hypoglycemic patient to an outside
facility.Anyepisodeofseverehypoglycemia
or recurrent episodes of mild to moderate
hypoglycemia require reevaluation of the
diabetes management plan by the medical
staff. In certain cases of unexplained or re-
current severe hypoglycemia, it may be ap-
propriatetoadmitthepatienttothemedical
unit for observation and stabilization of di-
abetes management.
Correctional institutions should have
systems in place to identify the patients at
greater risk for hypoglycemia (i.e., those
oninsulinorsulfonylureatherapy)andto
ensure the early detection and treatment
of hypoglycemia. If possible, patients at
greater risk of severe hypoglycemia (e.g.,
thosewithapriorepisodeofseverehypo-
glycemia) may be housed in units closer
to the medical unit in order to minimize
delay in treatment.
Recommendations
● Train correctional staff in the recogni-
tion, treatment, and appropriate refer-
ral for hypo- and hyperglycemia. (E)
● Train appropriate staff to administer
glucagon. (E)
● Train staff to recognize symptoms and
signsofseriousmetabolicdecompensa-
tion, and immediately refer the patient
for appropriate medical care. (E)
● Institutions should implement a policy
requiring staff to notify a physician of
all CBG results outside of a speciﬁed
range, as determined by the treating
physician (e.g., 50 or 350 mg/dl).
(E)
● Identify patients with type 1 diabetes
who are at high risk for DKA. (E)
Table 1—Summary of recommendations for glycemic, blood pressure, and lipid control for
adults with diabetes
A1C 7.0%*
Blood pressure 130/80 mmHg
Lipids
LDL cholesterol 100 mg/dl (2.6 mmol/l)†
*Referencedtoanondiabeticrangeof4.0–6.0%usingaDCCT-basedassay.†InindividualswithovertCVD,
a lower LDL cholesterol goal of 70 mg/dl (1.8 mmol/l), using a high dose of a statin, is an option.
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provide access to usual and customary oral
medications and insulins necessary to treat
diabetes and related conditions. While not
every brand name of insulin and oral med-
ication needs to be available, individual pa-
tient care requires access to short-,
medium-, and long-acting insulins and the
various classes of oral medications (e.g., in-
sulin secretagogues, biguanides, -glucosi-
dase inhibitors, and thiazolidinediones)
necessaryforcurrentdiabetesmanagement.
Patientsatalllevelsofcustodyshould
have access to medication at dosing fre-
quencies that are consistent with their
treatment plan and medical direction. If
feasible and consistent with security con-
cerns,patientsonmultipledosesofshort-
acting oral medications should be placed
in a “keep on person” program. In other
situations, patients should be permitted
toself-injectinsulinwhenconsistentwith
security needs. Medical department
nurses should determine whether pa-
tientshavethenecessaryskillandrespon-
sible behavior to be allowed self-
administration and the degree of
supervisionnecessary.Whenneeded,this
skillshouldbeapartofpatienteducation.
Reasonable syringe control systems
should be established.
In the past, the recommendation that
regularinsulinbeinjected30–45minbe-
fore meals presented a signiﬁcant prob-
lem when “lock downs” or other
disruptions to the normal schedule of
meals and medications occurred. The use
of multiple-dose insulin regimens using
rapid-acting analogs can decrease the dis-
ruption caused by such changes in sched-
ule. Correctional institutions should have
systems in place to ensure that rapid-
acting insulin analogs and oral agents are
given immediately before meals if this is
part of the patient’s medical plan. It
should be noted however that even mod-
estdelaysinmealconsumptionwiththese
agents can be associated with hypoglyce-
mia.Ifconsistentaccesstofoodwithin10
min cannot be ensured, rapid-acting in-
sulin analogs and oral agents are ap-
proved for administration during or
immediately after meals. Should circum-
stances arise that delay patient access to
regular meals following medication ad-
ministration, policies and procedures
must be implemented to ensure the pa-
tient receives appropriate nutrition to
prevent hypoglycemia.
Both continuous subcutaneous insu-
lin infusion and multiple daily insulin in-
jection therapy (consisting of three or
more injections a day) can be effective
means of implementing intensive diabe-
tes management with the goal of achiev-
ing near-normal levels of blood glucose
(9).Whiletheuseofthesemodalitiesmay
be difﬁcult in correctional institutions,
every effort should be made to continue
multiple daily insulin injection or contin-
uous subcutaneous insulin infusion in
people who were using this therapy be-
fore incarceration or to institute these
therapies as indicated in order to achieve
blood glucose targets.
Itisessentialthattransportofpatients
from jails or prisons to off-site appoint-
ments, such as medical visits or court ap-
pearances, does not cause signiﬁcant
disruption in medication or meal timing.
Correctional institutions and police lock-
ups should implement policies and pro-
cedures to diminish the risk of hypo- and
hyperglycemiaby,forexample,providing
carry-along meals and medication for pa-
tientstravelingtooff-siteappointmentsor
changingtheinsulinregimenforthatday.
The availability of preﬁlled insulin “pens”
provides an alternative for off-site insulin
delivery.
Recommendations
● Formularies should provide access to
usual and customary oral medications
and insulins to treat diabetes and re-
lated conditions. (E)
● Patients should have access to medica-
tion at dosing frequencies that are con-
sistent with their treatment plan and
medical direction. (E)
● Correctional institutions and police
lock-ups should implement policies
and procedures to diminish the risk of
hypo- and hyperglycemia during off-
site travel (e.g., court appearances). (E)
ROUTINE SCREENING FOR
AND MANAGEMENT OF
DIABETES COMPLICATIONS—
All patients with a diagnosis of diabetes
should receive routine screening for dia-
betes-relatedcomplications,asdetailedin
the ADA Standards of Care (4). Interval
chronic disease clinics for persons with
diabetes provide an efﬁcient mechanism
to monitor patients for complications of
diabetes.Inthisway,appropriatereferrals
to consultant specialists, such as optome-
trists/ophthalmologists, nephrologists,
and cardiologists, can be made on an as-
needed basis and interval laboratory test-
ing can be done.
The following complications should
be considered.
● Foot care: Recommendations for foot
care for patients with diabetes and no
history of an open foot lesion are de-
scribedintheADAStandardsofCare.A
comprehensivefootexaminationisrec-
ommended annually for all patients
with diabetes to identify risk factors
predictive of ulcers and amputations.
Persons with an insensate foot, an open
foot lesion, or a history of such a lesion
should be referred for evaluation by an
appropriate licensed health profes-
sional (e.g., podiatrist or vascular sur-
geon). Special shoes should be
provided as recommended by licensed
health professionals to aid healing of
foot lesions and to prevent develop-
ment of new lesions.
● Retinopathy: Annual retinal examina-
tionsbyalicensedeyecareprofessional
should be performed for all patients
with diabetes, as recommended in the
ADA Standards of Care. Visual changes
that cannot be accounted for by acute
changes in glycemic control require
prompt evaluation by an eye care pro-
fessional.
● Nephropathy:Anannualspoturinetest
for determination of microalbumin-to-
creatinine ratio should be performed.
The use of ACE inhibitors or angioten-
sin receptor blockers is recommended
forallpatientswithalbuminuria.Blood
pressure should be controlled to
130/80 mmHg.
● Cardiac:Peoplewithtype2diabetesare
at a particularly high risk of coronary
artery disease. Cardiovascular disease
risk factor management is of demon-
strated beneﬁt in reducing this compli-
cation in patients with diabetes. Blood
pressure should be measured at every
routine diabetes visit. In adult patients,
test for lipid disorders at least annually
and as needed to achieve goals with
treatment.Useaspirintherapy(75–162
mg/day) in all adult patients with dia-
betes and cardiovascular risk factors or
known macrovascular disease. Current
national standards for adults with dia-
betescallfortreatmentoflipidstogoals
of LDL 100, HDL 40, triglycerides
150 mg/dl and blood pressure to a
level of 130/80 mmHg.
MONITORING/TESTS OF
GLYCEMIA— Monitoring of CBG is
a strategy that allows caregivers and peo-
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management regimens. The frequency of
monitoringwillvarybypatients’glycemic
control and diabetes regimens. Patients
with type 1 diabetes are at risk for hypo-
glycemia and should have their CBG
monitored three or more times daily. Pa-
tientswithtype2diabetesoninsulinneed
to monitor at least once daily and more
frequently based on their medical plan.
Patients treated with oral agents should
have CBG monitored with sufﬁcient fre-
quency to facilitate the goals of glycemic
control, assuming that there is a program
for medical review of these data on an
ongoingbasistodrivechangesinmedica-
tions. Patients whose diabetes is poorly
controlled or whose therapy is changing
should have more frequent monitoring.
Unexplained hyperglycemia in a patient
withtype1diabetesmaysuggestimpend-
ing DKA, and monitoring of ketones
should therefore be performed.
Glycated hemoglobin (A1C) is a mea-
sure of long-term (2- to 3-month) glyce-
mic control. Perform the A1C test at least
twotimesayearinpatientswhoaremeet-
ing treatment goals (and who have stable
glycemic control) and quarterly in pa-
tients whose therapy has changed or who
are not meeting glycemic goals.
DiscrepanciesbetweenCBGmonitor-
ingresultsandA1Cmayindicateahemo-
globinopathy, hemolysis, or need for
evaluation of CBG monitoring technique
and equipment or initiation of more fre-
quent CBG monitoring to identify when
glycemic excursions are occurring and
which facet of the diabetes regimen is
changing.
In the correctional setting, policies
andproceduresneedtobedevelopedand
implemented regarding CBG monitoring
that address the following.
● infection control
● education of staff and patients
● proper choice of meter
● disposal of testing lancets
● quality control programs
● access to health services
● size of the blood sample
● patient performance skills
● documentation and interpretation of
test results
● availability of test results for the health
care provider (10)
Recommendations
● In the correctional setting, policies and
procedures need to be developed and
implemented to enable CBG monitor-
ing to occur at the frequency necessi-
tated by the individual patient’s
glycemic control and diabetes regimen.
(E)
● A1C should be checked every 3–6
months. (E)
SELF-MANAGEMENT
EDUCATION— Self-management
education is the cornerstone of treatment
for all people with diabetes. The health
staff must advocate for patients to partic-
ipate in self-management as much as pos-
sible. Individuals with diabetes who learn
self-management skills and make lifestyle
changes can more effectively manage
their diabetes and avoid or delay compli-
cations associated with diabetes. In the
development of a diabetes self-
management education program in the
correctional environment, the unique cir-
cumstances of the patient should be con-
sidered while still providing, to the
greatest extent possible, the elements of
the “National Standards for Diabetes Self-
Management Education” (11). A staged
approach may be used depending on the
needs assessment and the length of incar-
ceration. Table 2 sets out the major com-
ponents of diabetes self-management
education. Survival skills should be ad-
dressed as soon as possible; other aspects
of education may be provided as part of
an ongoing education program.
Ideally,self-managementeducationis
coordinatedbyacertiﬁeddiabeteseduca-
tor who works with the facility to develop
polices, procedures, and protocols to en-
sure that nationally recognized education
guidelines are implemented. The educa-
tor is also able to identify patients who
need diabetes self-management educa-
tion, including an assessment of the pa-
tients’ medical, social, and diabetes
histories; diabetes knowledge, skills, and
behaviors; and readiness to change.
STAFF EDUCATION— Policies and
proceduresshouldbeimplementedtoen-
surethatthehealthcarestaffhasadequate
knowledge and skills to direct the man-
agement and education of persons with
diabetes. The health care staff needs to be
involved in the development of the cor-
rectional ofﬁcers’ training program. The
staff education program should be at a lay
level. Training should be offered at least
biannually, and the curriculum should
cover the following.
● what diabetes is
● signs and symptoms of diabetes
● risk factors
● signs and symptoms of, and emergency
response to, hypo- and hyperglycemia
● glucose monitoring
● medications
● exercise
● nutrition issues including timing of
meals and access to snacks
Recommendations
● Include diabetes in correctional staff
education programs. (E)
ALCOHOL AND DRUGS—P a -
tients with diabetes who are withdrawing
fromdrugsandalcoholneedspecialconsid-
eration. This issue particularly affects initial
policecustodyandjails.Atanintakefacility,
proper initial identiﬁcation and assessment
ofthesepatientsarecritical.Thepresenceof
diabetes may complicate detoxiﬁcation. Pa-
tients in need of complicated detoxiﬁcation
should be referred to a facility equipped to
deal with high-risk detoxiﬁcation. Patients
with diabetes should be educated in the
risks involved with smoking. All inmates
should be advised not to smoke. Assistance
insmokingcessationshouldbeprovidedas
practical.
TRANSFER AND
DISCHARGE— Patients in jails may
be housed for a short period of time be-
forebeingtransferredorreleased,anditis
not unusual for patients in prison to be
transferred within the system several
times during their incarceration. One of
the many challenges that health care pro-
viders face working in the correctional
system is how to best collect and commu-
nicate important health care information
in a timely manner when a patient is in
initial police custody, is jailed short term,
or is transferred from facility to facility.
The importance of this communication
becomes critical when the patient has a
chronic illness such as diabetes.
Transferring a patient with diabetes
from one correctional facility to another
requires a coordinated effort. To facilitate
athoroughreviewofmedicalinformation
and completion of a transfer summary, it
iscriticalforcustodypersonneltoprovide
medical staff with sufﬁcient notice before
movement of the patient.
Before the transfer, the health care
staff should review the patient’s medical
record and complete a medical transfer
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renthealthcareissues.Ataminimum,the
summary should include the following.
● the patient’s current medication sched-
ule and dosages
● the date and time of the last medication
administration
● any recent monitoring results (e.g.,
CBG and A1C)
● other factors that indicate a need for
immediatetreatmentormanagementat
the receiving facility (e.g., recent epi-
sodes of hypoglycemia, history of se-
vere hypoglycemia or frequent DKA,
concurrent illnesses, presence of diabe-
tes complications)
● information on scheduled treatment/
appointments if the receiving facility is
responsible for transporting the patient
to that appointment
● name and telephone/fax number of a
contact person at the transferring facil-
ity who can provide additional infor-
mation, if needed
The medical transfer summary,
which acts as a quick medical reference
for the receiving facility, should be trans-
ferred along with the patient. To supple-
ment the ﬂow of information and to
increase the probability that medications
arecorrectlyidentiﬁedatthereceivingin-
stitution, sending institutions are encour-
aged to provide each patient with a
medication card to be carried by the pa-
tient that contains information concern-
ing diagnoses, medication names,
dosages, and frequency. Diabetes sup-
plies, including diabetes medication,
should accompany the patient.
The sending facility must be mindful
ofthetransfertimeinordertoprovidethe
patient with medication and food if
needed.Thetransfersummaryormedical
record should be reviewed by a health
careprovideruponarrivalatthereceiving
institution.
Planning for patients’ discharge from
prisons should include instruction in the
long-term complications of diabetes, the
necessary lifestyle changes and examina-
tions required to prevent these complica-
tions,and,ifpossible,wherepatientsmay
obtain regular follow-up medical care. A
quarterly meeting to educate patients
withupcomingdischargesaboutcommu-
nity resources can be valuable. Inviting
community agencies to speak at these
meetings and/or provide written materi-
als can help strengthen the community
link for patients discharging from correc-
tional facilities.
Discharge planning for the patients
with diabetes should begin 1 month be-
fore discharge. During this time, applica-
tion for appropriate entitlements should
be initiated. Any gaps in the patient’s
knowledge of diabetes care need to be
identiﬁed and addressed. It is helpful if
the patient is given a directory or list of
community resources and if an appoint-
ment for follow-up care with a commu-
nity provider is made. A supply of
medication adequate to last until the ﬁrst
postrelease medical appointment should
be provided to the patient upon release.
The patient should be provided with a
written summary of his/her current heath
care issues, including medications and
doses, recent A1C values, etc.
Recommendations
● Forallinterinstitutionaltransfers,com-
plete a medical transfer summary to be
transferred with the patient. (E)
● Diabetes supplies and medication
should accompany the patient during
transfer. (E)
● Begin discharge planning with ade-
quate lead time to insure continuity of
care and facilitate entry into commu-
nity diabetes care. (E)
SHARING OF MEDICAL
INFORMATION AND
RECORDS— Practical considerations
may prohibit obtaining medical records
from providers who treated the patient
before arrest. Intake facilities should im-
plement policies that 1) deﬁne the cir-
cumstances under which prior medical
records are obtained (e.g., for patients
who have an extensive history of treat-
ment for complications); 2) identify per-
son(s)responsibleforcontactingtheprior
provider; and 3) establish procedures for
tracking requests.
Facilities that use outside medical
providers should implement policies and
proceduresforensuringthatkeyinforma-
tion (e.g., test results, diagnoses, physi-
cians’ orders, appointment dates) is
received from the provider and incorpo-
rated into the patient’s medical chart after
each outside appointment. The proce-
dure should include, at a minimum, a
means to highlight when key information
hasnotbeenreceivedanddesignationofa
personresponsibleforcontactingtheout-
side provider for this information.
All medical charts should contain
CBG test results in a speciﬁed, readily ac-
cessible section and should be reviewed
on a regular basis.
CHILDREN AND
ADOLESCENTS WITH
DIABETES— Children and adoles-
cents with diabetes present special prob-
lems in disease management, even
outside the setting of a correctional insti-
tution. Children and adolescents with di-
abetes should have initial and follow-up
care with physicians who are experienced
in their care. Conﬁnement increases the
difﬁculty in managing diabetes in chil-
dren and adolescents, as it does in adults
with diabetes. Correctional authorities
also have different legal obligations for
children and adolescents.
Nutrition and activity
Growing children and adolescents have
greater caloric/nutritional needs than
adults. The provision of an adequate
amount of calories and nutrients for ado-
lescents is critical to maintaining good
nutritionalstatus.Physicalactivityshould
be provided at the same time each day. If
increased physical activity occurs, addi-
Table 2—Major components of diabetes self-management education
Survival skills Daily management issues
• hypo-/hyperglycemia • disease process
• sick day management • nutritional management
• medication • physical activity
• monitoring • medications
• foot care • monitoring
• acute complications
• risk reduction
• goal setting/problem solving
• psychosocial adjustment
• preconception care/pregnancy/gestational diabetes
management
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additional carbohydrate snacks may be
required.
Medical management and follow-up
Childrenandadolescentswhoareincarcer-
ated for extended periods should have fol-
low-up visits at least every 3 months with
individuals who are experienced in the care
of children and adolescents with diabetes.
Thyroid function tests and fasting lipid and
microalbumin measurements should be
performed according to recognized stan-
dards for children and adolescents (12) in
order to monitor for autoimmune thyroid
disease and complications and comorbidi-
ties of diabetes.
Children and adolescents with diabe-
tes exhibiting unusual behavior should
have their CBG checked at that time. Be-
cause children and adolescents are re-
ported to have higher rates of nocturnal
hypoglycemia (13), consideration should
be given regarding the use of episodic
overnight blood glucose monitoring in
these patients. In particular, this should
beconsideredinchildrenandadolescents
who have recently had their overnight in-
sulin dose changed.
PREGNANCY— Pregnancy in a
woman with diabetes is by deﬁnition a
high-risk pregnancy. Every effort should
be made to ensure that treatment of the
pregnant woman with diabetes meets ac-
cepted standards (14,15). It should be
noted that glycemic standards are more
stringent, the details of dietary manage-
ment are more complex and exacting, in-
sulin is the only antidiabetic agent
approved for use in pregnancy, and a
number of medications used in the man-
agement of diabetic comorbidities are
known to be teratogenic and must be dis-
continued in the setting of pregnancy.
SUMMARY AND KEY
POINTS— People with diabetes
should receive care that meets national
standards. Being incarcerated does not
change these standards. Patients must
have access to medication and nutrition
needed to manage their disease. In pa-
tients who do not meet treatment targets,
medical and behavioral plans should be
adjusted by health care professionals in
collaboration with the prison staff. It is
critical for correctional institutions to
identify particularly high-risk patients in
need of more intensive evaluation and
therapy, including pregnant women, pa-
tientswithadvancedcomplications,ahis-
tory of repeated severe hypoglycemia, or
recurrent DKA.
A comprehensive, multidisciplinary
approach to the care of people with dia-
betes can be an effective mechanism to
improve overall health and delay or pre-
vent the acute and chronic complications
of this disease.
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